Insider: Fitzgerald Kevin Joseph CSO & EVP, Head of Research - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 20,569 | 0 | 20,569 |
| Value | $6,558,425.65 | $0.00 | $6,558,425.65 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/05/2026 | DDS | 153 | Direct | COM | $326.24 | $49,914.72 | 20,569 |
| 03/05/2026 | DDS | 233 | Direct | COM | $323.25 | $75,317.25 | 20,870 |
| 03/05/2026 | DDS | 124 | Direct | COM | $321.81 | $39,904.44 | 21,103 |
| 03/05/2026 | DDS | 148 | Direct | COM | $324.60 | $48,040.80 | 20,722 |
| 03/04/2026 | DDS | 28 | Direct | COM | $320.01 | $8,960.28 | 21,803 |
| 03/04/2026 | DDS | 29 | Direct | COM | $319.03 | $9,251.87 | 21,831 |
| 03/04/2026 | DDS | 79 | Direct | COM | $321.82 | $25,423.78 | 21,665 |
| 03/04/2026 | DDS | 59 | Direct | COM | $320.81 | $18,927.79 | 21,744 |
| 03/04/2026 | DDS | 96 | Direct | COM | $323.01 | $31,008.96 | 21,569 |
| 03/04/2026 | DDS | 75 | Direct | COM | $324.88 | $24,366.00 | 21,284 |
| 03/04/2026 | DDS | 210 | Direct | COM | $323.84 | $68,006.40 | 21,359 |
| 03/04/2026 | DDS | 57 | Direct | COM | $325.67 | $18,563.19 | 21,227 |
| 03/03/2026 | DDS | 289 | Direct | COM | $316.55 | $91,482.95 | 23,223 |
| 03/03/2026 | DDS | 282 | Direct | COM | $318.62 | $89,850.84 | 22,941 |
| 03/03/2026 | DDS | 722 | Direct | COM | $320.51 | $231,408.22 | 22,219 |
| 03/03/2026 | DDS | 359 | Direct | COM | $321.58 | $115,447.22 | 21,860 |
| 03/02/2026 | DDS | 258 | Direct | COM | $325.63 | $84,012.54 | 24,715 |
| 03/02/2026 | DDS | 90 | Direct | COM | $324.65 | $29,218.50 | 24,973 |
| 03/02/2026 | DDS | 47 | Direct | COM | $323.62 | $15,210.14 | 25,063 |
| 03/02/2026 | DDS | 392 | Direct | COM | $326.81 | $128,109.52 | 24,323 |
| 03/02/2026 | DDS | 329 | Direct | COM | $327.67 | $107,803.43 | 23,994 |
| 03/02/2026 | DDS | 37 | Direct | COM | $332.64 | $12,307.68 | 23,512 |
| 03/02/2026 | DDS | 81 | Direct | COM | $330.85 | $26,798.85 | 23,643 |
| 03/02/2026 | DDS | 94 | Direct | COM | $331.93 | $31,201.42 | 23,549 |
| 03/02/2026 | DDS | 100 | Direct | COM | $328.71 | $32,871.00 | 23,894 |
| 1 2 3 4 5 6 7 Next Last You are at page 1 of 7 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research